IBDEI0CZ ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,17461,0)
 ;;=428.42^^116^993^42
 ;;^UTILITY(U,$J,358.3,17461,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17461,1,4,0)
 ;;=4^428.42
 ;;^UTILITY(U,$J,358.3,17461,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Chronic
 ;;^UTILITY(U,$J,358.3,17461,2)
 ;;= Heart Failure, Systolic & Diastolic, Chronic^328501
 ;;^UTILITY(U,$J,358.3,17462,0)
 ;;=428.43^^116^993^41
 ;;^UTILITY(U,$J,358.3,17462,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17462,1,4,0)
 ;;=4^428.43
 ;;^UTILITY(U,$J,358.3,17462,1,5,0)
 ;;=5^Heart Failure, Systolic & Diastolic, Acute On Chronic
 ;;^UTILITY(U,$J,358.3,17462,2)
 ;;= Heart Failure, Systolic & Diastolic, Acute on Chronic^328502
 ;;^UTILITY(U,$J,358.3,17463,0)
 ;;=396.3^^116^993^7
 ;;^UTILITY(U,$J,358.3,17463,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17463,1,4,0)
 ;;=4^396.3
 ;;^UTILITY(U,$J,358.3,17463,1,5,0)
 ;;=5^Aortic And Mitral Insufficiency
 ;;^UTILITY(U,$J,358.3,17463,2)
 ;;=Aortic and Mitral Insufficiency^269583
 ;;^UTILITY(U,$J,358.3,17464,0)
 ;;=414.3^^116^993^17
 ;;^UTILITY(U,$J,358.3,17464,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17464,1,4,0)
 ;;=4^414.3
 ;;^UTILITY(U,$J,358.3,17464,1,5,0)
 ;;=5^CAD d/t Lipid Rich Plaque
 ;;^UTILITY(U,$J,358.3,17464,2)
 ;;=^336601
 ;;^UTILITY(U,$J,358.3,17465,0)
 ;;=453.9^^116^993^82
 ;;^UTILITY(U,$J,358.3,17465,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17465,1,4,0)
 ;;=4^453.9
 ;;^UTILITY(U,$J,358.3,17465,1,5,0)
 ;;=5^Venous Thrombosis NOS
 ;;^UTILITY(U,$J,358.3,17465,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,17466,0)
 ;;=453.89^^116^993^1
 ;;^UTILITY(U,$J,358.3,17466,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17466,1,4,0)
 ;;=4^453.89
 ;;^UTILITY(U,$J,358.3,17466,1,5,0)
 ;;=5^AC Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,17466,2)
 ;;=^338259
 ;;^UTILITY(U,$J,358.3,17467,0)
 ;;=453.79^^116^993^27
 ;;^UTILITY(U,$J,358.3,17467,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17467,1,4,0)
 ;;=4^453.79
 ;;^UTILITY(U,$J,358.3,17467,1,5,0)
 ;;=5^Chr Venous Embolism NEC
 ;;^UTILITY(U,$J,358.3,17467,2)
 ;;=^338251
 ;;^UTILITY(U,$J,358.3,17468,0)
 ;;=425.11^^116^993^58
 ;;^UTILITY(U,$J,358.3,17468,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17468,1,4,0)
 ;;=4^425.11
 ;;^UTILITY(U,$J,358.3,17468,1,5,0)
 ;;=5^Hypertrophic Subaortic Stenosis
 ;;^UTILITY(U,$J,358.3,17468,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,17469,0)
 ;;=425.18^^116^993^63
 ;;^UTILITY(U,$J,358.3,17469,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17469,1,4,0)
 ;;=4^425.18
 ;;^UTILITY(U,$J,358.3,17469,1,5,0)
 ;;=5^Oth Hypertrophic Cardiomyopathy
 ;;^UTILITY(U,$J,358.3,17469,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,17470,0)
 ;;=V12.55^^116^993^53
 ;;^UTILITY(U,$J,358.3,17470,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17470,1,4,0)
 ;;=4^V12.55
 ;;^UTILITY(U,$J,358.3,17470,1,5,0)
 ;;=5^Hx of Pulmonary Embolism
 ;;^UTILITY(U,$J,358.3,17470,2)
 ;;=^340615
 ;;^UTILITY(U,$J,358.3,17471,0)
 ;;=414.4^^116^993^16
 ;;^UTILITY(U,$J,358.3,17471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17471,1,4,0)
 ;;=4^414.4
 ;;^UTILITY(U,$J,358.3,17471,1,5,0)
 ;;=5^CAD d/t Calc Coronary Lesion
 ;;^UTILITY(U,$J,358.3,17471,2)
 ;;=^340518
 ;;^UTILITY(U,$J,358.3,17472,0)
 ;;=271.3^^116^994^11
 ;;^UTILITY(U,$J,358.3,17472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17472,1,4,0)
 ;;=4^271.3
 ;;^UTILITY(U,$J,358.3,17472,1,5,0)
 ;;=5^Glucose Intolerance
 ;;^UTILITY(U,$J,358.3,17472,2)
 ;;=^64790
 ;;^UTILITY(U,$J,358.3,17473,0)
 ;;=611.1^^116^994^16
 ;;^UTILITY(U,$J,358.3,17473,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17473,1,4,0)
 ;;=4^611.1
 ;;^UTILITY(U,$J,358.3,17473,1,5,0)
 ;;=5^Gynecomastia
 ;;^UTILITY(U,$J,358.3,17473,2)
 ;;=^60454
 ;;^UTILITY(U,$J,358.3,17474,0)
 ;;=704.1^^116^994^17
 ;;^UTILITY(U,$J,358.3,17474,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17474,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,17474,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,17474,2)
 ;;=^57407
 ;;^UTILITY(U,$J,358.3,17475,0)
 ;;=251.2^^116^994^29
 ;;^UTILITY(U,$J,358.3,17475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17475,1,4,0)
 ;;=4^251.2
 ;;^UTILITY(U,$J,358.3,17475,1,5,0)
 ;;=5^Hypoglycemia Nos
 ;;^UTILITY(U,$J,358.3,17475,2)
 ;;=^60580
 ;;^UTILITY(U,$J,358.3,17476,0)
 ;;=257.2^^116^994^30
 ;;^UTILITY(U,$J,358.3,17476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17476,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,17476,1,5,0)
 ;;=5^Hypogonadism,Male
 ;;^UTILITY(U,$J,358.3,17476,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,17477,0)
 ;;=253.2^^116^994^33
 ;;^UTILITY(U,$J,358.3,17477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17477,1,4,0)
 ;;=4^253.2
 ;;^UTILITY(U,$J,358.3,17477,1,5,0)
 ;;=5^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,17477,2)
 ;;=^60686
 ;;^UTILITY(U,$J,358.3,17478,0)
 ;;=733.00^^116^994^43
 ;;^UTILITY(U,$J,358.3,17478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17478,1,4,0)
 ;;=4^733.00
 ;;^UTILITY(U,$J,358.3,17478,1,5,0)
 ;;=5^Osteoporosis Nos
 ;;^UTILITY(U,$J,358.3,17478,2)
 ;;=^87159
 ;;^UTILITY(U,$J,358.3,17479,0)
 ;;=278.00^^116^994^40
 ;;^UTILITY(U,$J,358.3,17479,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17479,1,4,0)
 ;;=4^278.00
 ;;^UTILITY(U,$J,358.3,17479,1,5,0)
 ;;=5^Obesity
 ;;^UTILITY(U,$J,358.3,17479,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,17480,0)
 ;;=278.01^^116^994^39
 ;;^UTILITY(U,$J,358.3,17480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17480,1,4,0)
 ;;=4^278.01
 ;;^UTILITY(U,$J,358.3,17480,1,5,0)
 ;;=5^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,17480,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,17481,0)
 ;;=250.80^^116^994^5
 ;;^UTILITY(U,$J,358.3,17481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17481,1,4,0)
 ;;=4^250.80
 ;;^UTILITY(U,$J,358.3,17481,1,5,0)
 ;;=5^DM Type II W/ LE Ulcer
 ;;^UTILITY(U,$J,358.3,17481,2)
 ;;=DM Type II with LE Ulcer^267846^707.10
 ;;^UTILITY(U,$J,358.3,17482,0)
 ;;=250.00^^116^994^4
 ;;^UTILITY(U,$J,358.3,17482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17482,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,17482,1,5,0)
 ;;=5^DM Type II  W/O Complications
 ;;^UTILITY(U,$J,358.3,17482,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,17483,0)
 ;;=250.40^^116^994^6
 ;;^UTILITY(U,$J,358.3,17483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17483,1,4,0)
 ;;=4^250.40
 ;;^UTILITY(U,$J,358.3,17483,1,5,0)
 ;;=5^DM Type II W/ Nephropathy
 ;;^UTILITY(U,$J,358.3,17483,2)
 ;;=^267837^583.81
 ;;^UTILITY(U,$J,358.3,17484,0)
 ;;=250.50^^116^994^8
 ;;^UTILITY(U,$J,358.3,17484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17484,1,4,0)
 ;;=4^250.50
 ;;^UTILITY(U,$J,358.3,17484,1,5,0)
 ;;=5^DM Type II W/ PDR
 ;;^UTILITY(U,$J,358.3,17484,2)
 ;;=DM Type II w/ PDR^267839^362.02
 ;;^UTILITY(U,$J,358.3,17485,0)
 ;;=250.60^^116^994^7
 ;;^UTILITY(U,$J,358.3,17485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17485,1,4,0)
 ;;=4^250.60
 ;;^UTILITY(U,$J,358.3,17485,1,5,0)
 ;;=5^DM Type II W/ Neuropathy
 ;;^UTILITY(U,$J,358.3,17485,2)
 ;;=^267841^357.2
 ;;^UTILITY(U,$J,358.3,17486,0)
 ;;=250.70^^116^994^9
 ;;^UTILITY(U,$J,358.3,17486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17486,1,4,0)
 ;;=4^250.70
 ;;^UTILITY(U,$J,358.3,17486,1,5,0)
 ;;=5^DM Type II W/ Peripheral Vasc Dis
 ;;^UTILITY(U,$J,358.3,17486,2)
 ;;=^267843^443.81
 ;;^UTILITY(U,$J,358.3,17487,0)
 ;;=250.01^^116^994^3
 ;;^UTILITY(U,$J,358.3,17487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17487,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,17487,1,5,0)
 ;;=5^DM Type I  W/O Complications
 ;;^UTILITY(U,$J,358.3,17487,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,17488,0)
 ;;=272.0^^116^994^22
 ;;^UTILITY(U,$J,358.3,17488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17488,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,17488,1,5,0)
 ;;=5^Hypercholesterolemia, Pure
 ;;^UTILITY(U,$J,358.3,17488,2)
 ;;=Hypercholesterolemia, Pure^59973
 ;;^UTILITY(U,$J,358.3,17489,0)
 ;;=272.1^^116^994^27
 ;;^UTILITY(U,$J,358.3,17489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17489,1,4,0)
 ;;=4^272.1
 ;;^UTILITY(U,$J,358.3,17489,1,5,0)
 ;;=5^Hypertriglyceridemia, Pure
 ;;^UTILITY(U,$J,358.3,17489,2)
 ;;=Hypertriglyceridemia, Pure^101303
 ;;^UTILITY(U,$J,358.3,17490,0)
 ;;=272.2^^116^994^24
 ;;^UTILITY(U,$J,358.3,17490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17490,1,4,0)
 ;;=4^272.2
 ;;^UTILITY(U,$J,358.3,17490,1,5,0)
 ;;=5^Hyperlipidemia, Mixed
 ;;^UTILITY(U,$J,358.3,17490,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,17491,0)
 ;;=275.42^^116^994^21
 ;;^UTILITY(U,$J,358.3,17491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17491,1,4,0)
 ;;=4^275.42
 ;;^UTILITY(U,$J,358.3,17491,1,5,0)
 ;;=5^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,17491,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,17492,0)
 ;;=275.41^^116^994^28
 ;;^UTILITY(U,$J,358.3,17492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17492,1,4,0)
 ;;=4^275.41
 ;;^UTILITY(U,$J,358.3,17492,1,5,0)
 ;;=5^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,17492,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,17493,0)
 ;;=276.7^^116^994^23
 ;;^UTILITY(U,$J,358.3,17493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17493,1,4,0)
 ;;=4^276.7
 ;;^UTILITY(U,$J,358.3,17493,1,5,0)
 ;;=5^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,17493,2)
 ;;=^60042
 ;;^UTILITY(U,$J,358.3,17494,0)
 ;;=275.2^^116^994^19
 ;;^UTILITY(U,$J,358.3,17494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17494,1,4,0)
 ;;=4^275.2
 ;;^UTILITY(U,$J,358.3,17494,1,5,0)
 ;;=5^Hyper Or Hypomagnesemia
 ;;^UTILITY(U,$J,358.3,17494,2)
 ;;=^35626
 ;;^UTILITY(U,$J,358.3,17495,0)
 ;;=276.0^^116^994^25
 ;;^UTILITY(U,$J,358.3,17495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17495,1,4,0)
 ;;=4^276.0
 ;;^UTILITY(U,$J,358.3,17495,1,5,0)
 ;;=5^Hypernatremia
 ;;^UTILITY(U,$J,358.3,17495,2)
 ;;=^60144
 ;;^UTILITY(U,$J,358.3,17496,0)
 ;;=276.1^^116^994^31
 ;;^UTILITY(U,$J,358.3,17496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,17496,1,4,0)
 ;;=4^276.1
 ;;^UTILITY(U,$J,358.3,17496,1,5,0)
 ;;=5^Hyponatremia
 ;;^UTILITY(U,$J,358.3,17496,2)
 ;;=Hyponatremia^60722
 ;;^UTILITY(U,$J,358.3,17497,0)
 ;;=275.3^^116^994^20
